NCT06404333View on ClinicalTrials.gov

Evaluating Pediatric Ivermectin in Children Under 15 kg (EPIC-15)

PHASE2RecruitingINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

February 25, 2025

Primary Completion Date

September 30, 2025

Study Completion Date

December 31, 2025

Conditions
Scabies
Interventions
DRUG

CHILD-IVITAB

Ivermectin (200 µg/kg) oro-dispersible minitablets

DRUG

CHILD-IVITAB

Ivermectin (400 µg/kg) oro-dispersible minitablets

Trial Locations (1)

69065-130

RECRUITING

Fundação de Dermatologia Tropical e Venereologia Alfredo da Matta (FUAM), Manaus

Sponsors

Collaborators (1)

ClinSearch
All Listed Sponsors
collaborator

Fundação de Medicina Tropical Dr. Heitor Vieira Dourado

OTHER

collaborator

Fundação de Dermatologia Tropical e Venereologia Alfredo da Matta (FUAM)

UNKNOWN

collaborator

University of Basel

OTHER

collaborator

ClinSearch

OTHER

lead

University of Oxford

OTHER

NCT06404333 - Evaluating Pediatric Ivermectin in Children Under 15 kg (EPIC-15) | Biotech Hunter | Biotech Hunter